Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus - Strong,P.; Reid,K.B.; Clark,H. (Clin Exp Immunol, 2002)